Evidence map›Paper›PMID 34684766›Full record

ArticleMolecules (Basel, Switzerland)2021

Improved Lipophilicity and Aqueous Solubility Prediction with Composite Graph Neural Networks.

Oliver Wieder, Mélaine Kuenemann, Marcus Wieder, Thomas Seidel, Christophe Meyer, Sharon D Bryant, Thierry Langer

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oliver WiederDepartment of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0003-4967-7613
Mélaine KuenemannServier Research Institute-CentEx Biotechnology, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.ORCID 0000-0001-5317-2111
Marcus WiederDepartment of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0003-2631-8415
Thomas SeidelDepartment of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0002-9815-6577
Christophe MeyerServier Research Institute-CentEx Biotechnology, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.ORCID 0000-0003-3785-1741
Sharon D BryantInte:Ligand Software Entwicklungs und Consulting GmbH, 74B/11 Mariahilferstrasse, 1070 Vienna, Austria.
Thierry LangerDepartment of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0002-5242-1240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate prediction of molecular properties, such as lipophilicity and aqueous solubility, are of great importance and pose challenges in several stages of the drug discovery pipeline. Machine learning methods, such as graph-based neural networks (GNNs), have shown exceptionally good performance in predicting these properties. In this work, we introduce a novel GNN architecture, called directed edge graph isomorphism network (D-GIN). It is composed of two distinct sub-architectures (D-MPNN, GIN) and achieves an improvement in accuracy over its sub-architectures employing various learning, and featurization strategies. We argue that combining models with different key aspects help make graph neural networks deeper and simultaneously increase their predictive power. Furthermore, we address current limitations in assessment of deep-learning models, namely, comparison of single training run performance metrics, and offer a more robust solution.

Indexed as

AI deep-learningcheminformaticscomputational chemistrygraph neural-networkslipophilicitymachine-learningmolecular propertyneural-networkssolubility

Identifiers

PMID34684766
PMCPMC8539502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.